Investigation of T-cell fitness and mechanisms of drug resistance in selinexor treated patients with relapsed/refractory multiple myeloma
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Karyopharm Therapeutics
Start Date
March 1, 2023
End Date
April 30, 2024
Administered By
Duke Cancer Institute
Awarded By
Karyopharm Therapeutics
Start Date
March 1, 2023
End Date
April 30, 2024